CoChat

Isoflavones and Postmenopausal Bone Health: A Viable Alternative to Estrogen Therapy?

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The rapidly growing postmenopausal population in the United States, and this population's high incidence and prevalence of osteoporosis and related morbidity and mortality herald an enormous public health burden for the coming decades. Estrogen replacement has been the mainstay of therapy for the prevention and treatment of osteoporosis in this estrogen-deficient population. However, long-term compliance with estrogen therapy generally is poor, and there are numerous concerns regarding its safety. The phytoestrogens are nonsteroidal plant-derived compounds that exhibit estrogenic activity at several sites. The isoflavones are one class of phytoestrogens derived largely from soy-based products. International popularity for menopausal therapy regimens containing isoflavones is growing rapidly. In this article, we review the existing data on isoflavones and postmenopausal bone health. DESIGN: A review of interventional trials examining isoflavones and bone in animals and humans. RESULTS: The data point to a reduction in bone resorption resulting from isoflavone/ipriflavone intake. CONCLUSIONS: The data on naturally occurring isoflavones are very limited but suggest that including them in the diet results in reduction in bone resorption caused by estrogen deficiency. The extensive data on ipriflavone, a synthetic isoflavone derivative, suggest that it is a useful and safe alternative to estrogen therapy in treating existing low bone mass or osteoporosis in postmenopausal women. Further studies are warranted to examine the utility of ipriflavone as a preventive agent, as well as the clinical efficacy of the naturally occurring isoflavones.

Overview

Integrity signals

Registry

Crossref · 10.1097/00042192-199906030-00010

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Research works printed but not linked: 6

  1. Cummings, 1989, Ann Intern Med, 149, 244, 10.1001/archinte.1989.00390110045010 · doi:10.1001/archinte.1989.00390110045010 · Paper page
  2. Masi, 1997, Int J Fertil Women Med, 42, 245
  3. Maleka, 1995, Environ Health Perspect, 103, 123
  4. Moule, 1963, Anim Breed Abstr, 31, 139
  5. Walters, 1982, Effect of a lignan (HPMF) on RNA synthesis in the rat Uterus, J Reprod Fertil, 66, 379
  6. Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor Endocrinology, 139, 4252

Cited by

See all 78

Metadata

Authors
Scheiber, M. D., & Rebar, R. W.
Affiliations
University of Cincinnati (US)
Venue
Menopause
Published
1999
Volume
6
Issue
3
Pages
233-241
ISSN
1072-3714 (ISSN-L)
OpenAlex
W2329583146
Cited by
74
References
17
Citations by year
2025: 1 · 2023: 1 · 2020: 1 · 2016: 1 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
4.87
Type
journal article
Language
en
Open access
closed
Locations
  • Menopause The Journal of The North American Menopause Society (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Phytoestrogen effects and research
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
isoflavones, phytoestrogens, postmenopausal osteoporosis, bone health, estrogen deficiency, estrogen replacement therapy, ipriflavone, bone resorption, soy products, hormone replacement therapy
MeSH terms
Aged, Animals, Clinical Trials as Topic, Disease Models, Animal, Female, Humans, Isoflavones, Middle Aged, Rabbits, Sensitivity and Specificity, Bone Density, Osteoporosis, Postmenopausal, Estrogen Replacement Therapy, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Isoflavones and Postmenopausal Bone Health: A Viable Alternative to Estrogen Therapy? https://app.cochat.ai/papers/10.1097/00042192-199906030-00010
The paper
Scheiber, M. D., & Rebar, R. W. (1999). Isoflavones and Postmenopausal Bone Health: A Viable Alternative to Estrogen Therapy? Menopause. https://doi.org/10.1097/00042192-199906030-00010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.